Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Epithelial Ovarian Cancer: A 20-Year Single-Center Experience.

Cancers (Basel) · 2021 · PMC7866406 · PMID 33572964

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Although criticisms are present in many of the published trials, a clear trend toward survival benefit with an acceptable side effect profile is evident, but controversy remains surrounding which patients could benefit most from HIPEC.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.